Related Experiment Video

Updated: Mar 19, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.3K

Identification of altered pathways in hypertrophic cardiomyopathy based on combined data of protein-protein

S W Zhang1, J Wang1, J Pan1

  • 1Department of Cardiology, Linyi People's Hospital, Linyi, Shandong Province, China.

Genetics and Molecular Research : GMR
|June 21, 2016
PubMed

Insights

This study identified key molecular pathways in hypertrophic cardiomyopathy (HCM) pathogenesis using protein-protein interaction networks. Findings reveal altered immune and signaling pathways, offering potential therapeutic targets for HCM.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Systems Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex genetic heart disease with poorly understood molecular mechanisms.
  • Identifying key molecular pathways is crucial for developing targeted therapies for HCM.

Purpose of the Study:

  • To identify molecular pathways significantly altered during hypertrophic cardiomyopathy (HCM) pathogenesis.
  • To leverage protein-protein interaction (PPI) data and pathway databases for network analysis.
  • To uncover potential therapeutic targets by analyzing differentially expressed genes (DEGs) and hub genes in HCM.

Main Methods:

  • Utilized the STRING database for protein-protein interaction (PPI) data and REACTOME for pathway information.
  • Identified differentially expressed genes (DEGs) and constructed a targeted gene network.
  • Screened for significantly altered pathways (P < 0.05) based on deviations from common interactions and validated through hub gene enrichment.

Main Results:

  • Identified 1085 DEGs and a network of 3631 interactions.
  • Discovered 30 significantly altered pathways, with top pathways involved in immune modulation, signal transduction, hemostasis, and G protein-coupled receptor signaling.
  • Confirmed enrichment of hub genes within altered pathways, particularly in innate immunity, general immune responses, and signal transduction.

Conclusions:

  • The study successfully identified critical molecular pathways implicated in HCM pathogenesis.
  • Altered immune and signal transduction pathways represent promising avenues for future HCM research and therapeutic development.
  • These findings provide a foundation for novel clinical strategies aimed at treating hypertrophic cardiomyopathy.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

10.7K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
636
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
591
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753